SCHEMBL25429553

SCHEMBL25429553

NS(=O)(=O)Cc1cc[nH]n1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 3/20 0.39
▸ CA9 Q16790 3/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA5A P35218 2/20 0.39
▸ CA12 O43570 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ CA3 P07451 1/20 0.37
▸ CA4 P22748 1/20 0.37
▸ CA6 P23280 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ CA7 P43166 1/20 0.37
▸ CA13 Q8N1Q1 1/20 0.37
▸ CA14 Q9ULX7 1/20 0.37
▸ CA5B Q9Y2D0 1/20 0.37
▸ KIF11 P52732 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27500441 0.79 — —
SCHEMBL3545881 0.79 POLB (0.31) LMNA
SCHEMBL3545877 0.79 — —
SCHEMBL244009 0.70 — —
SCHEMBL1185934 0.70 — —
Sulfuric Acid SCHEMBL9355340 0.69 ALDH1A1 (0.32) —
SCHEMBL4588217 0.69 — —
SCHEMBL6421776 0.69 ALOX5AP (0.41) CA2CA9CA1CA5ACA12
SCHEMBL1821806 0.69 — —
Hydrochloric Acid SCHEMBL18344847 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214197-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS Nura Bio, Inc. (US) 2023-07-26 — — EP claimed
WO-2022060812-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. (US) 2022-03-24 — — WO claimed
EP-4214197-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS Nura Bio, Inc. (US) 2023-07-26 — — EP disclosed
CN-110678177-B Pyrazole MAGL inhibitors H.隆德贝克有限公司 2023-06-13 — — CN disclosed
WO-2022060812-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. (US) 2022-03-24 — — WO disclosed
Send feedback